Logo Logo
Hilfe
Hilfe
Switch Language to English

Sen, Tathambika Tejeswini; Kale, Ajinath; Lech, Maciej; Anders, Hans-Joachim und Gaikwad, Anil Bhanudas (2022): Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins. In: Drug Discovery Today, Bd. 28, Nr. 2: S. 1-10

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Worldwide, around 850 million people are diagnosed with kidney disease but the available treatment options are still limited. Preclinical studies propose a plethora of druggable targets that can attenuate kidney disease and could qualify as novel therapeutic strategies, although most of these targets still await clinical testing. Here, we review some promising candidate targets for chronic kidney disease: intermedin, periostin, sirtuin, the cannabinoid receptor, Klotho, and uromodulin. For acute kidney injury, we discuss Apelin, Elabela, growth differentiation factor-15, Fyn kinase, and Klotho. Target selection for further clinical development should consider redundancies with the standard of care, potential synergistic effects with existing treatments, as well as the potential of additional effects on the cardiovascular system as a common comorbidity in patients with kidney disease.

Dokument bearbeiten Dokument bearbeiten